Lessons from Cancer Immunoediting in Cutaneous Melanoma

We will revisit the dual role of the immune system in controlling and enabling tumor progression, known as cancer immunoediting. We will go through the different phases of this phenomenon, exposing the most relevant evidences obtained from experimental models and human clinical data, with special fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariana Aris, María Marcela Barrio, José Mordoh
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/192719
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565064375205888
author Mariana Aris
María Marcela Barrio
José Mordoh
author_facet Mariana Aris
María Marcela Barrio
José Mordoh
author_sort Mariana Aris
collection DOAJ
description We will revisit the dual role of the immune system in controlling and enabling tumor progression, known as cancer immunoediting. We will go through the different phases of this phenomenon, exposing the most relevant evidences obtained from experimental models and human clinical data, with special focus on Cutaneous Melanoma, an immunogenic tumor per excellence. We will describe the different immunotherapeutic strategies employed and consider current models accounting for tumor heterogeneity. And finally, we will propose a rational discussion of the progress made and the future challenges in the therapeutics of Cutaneous Melanoma, taking into consideration that tumor evolution is the resulting from a continuous feedback between tumor cells and their environment, and that different combinatorial therapeutic approaches can be implemented according to the tumor stage.
format Article
id doaj-art-da741e25fde146eab6d7b20580858d0e
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-da741e25fde146eab6d7b20580858d0e2025-02-03T01:09:33ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/192719192719Lessons from Cancer Immunoediting in Cutaneous MelanomaMariana Aris0María Marcela Barrio1José Mordoh2Laboratorio de Cancerología, Fundación Instituto Leloir, IIBBA-CONICET, Avenida Patricias Argentinas 435, 1405 Buenos Aires, ArgentinaCentro de Investigaciones Oncológicas, Fundación Cáncer and Instituto Alexander Fleming, 1426 Buenos Aires, ArgentinaLaboratorio de Cancerología, Fundación Instituto Leloir, IIBBA-CONICET, Avenida Patricias Argentinas 435, 1405 Buenos Aires, ArgentinaWe will revisit the dual role of the immune system in controlling and enabling tumor progression, known as cancer immunoediting. We will go through the different phases of this phenomenon, exposing the most relevant evidences obtained from experimental models and human clinical data, with special focus on Cutaneous Melanoma, an immunogenic tumor per excellence. We will describe the different immunotherapeutic strategies employed and consider current models accounting for tumor heterogeneity. And finally, we will propose a rational discussion of the progress made and the future challenges in the therapeutics of Cutaneous Melanoma, taking into consideration that tumor evolution is the resulting from a continuous feedback between tumor cells and their environment, and that different combinatorial therapeutic approaches can be implemented according to the tumor stage.http://dx.doi.org/10.1155/2012/192719
spellingShingle Mariana Aris
María Marcela Barrio
José Mordoh
Lessons from Cancer Immunoediting in Cutaneous Melanoma
Clinical and Developmental Immunology
title Lessons from Cancer Immunoediting in Cutaneous Melanoma
title_full Lessons from Cancer Immunoediting in Cutaneous Melanoma
title_fullStr Lessons from Cancer Immunoediting in Cutaneous Melanoma
title_full_unstemmed Lessons from Cancer Immunoediting in Cutaneous Melanoma
title_short Lessons from Cancer Immunoediting in Cutaneous Melanoma
title_sort lessons from cancer immunoediting in cutaneous melanoma
url http://dx.doi.org/10.1155/2012/192719
work_keys_str_mv AT marianaaris lessonsfromcancerimmunoeditingincutaneousmelanoma
AT mariamarcelabarrio lessonsfromcancerimmunoeditingincutaneousmelanoma
AT josemordoh lessonsfromcancerimmunoeditingincutaneousmelanoma